ABC Arbitrage’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-369,120
Closed -$17.7M – 464
2026
Q2
$17.7M Buy
+369,120
New +$15.9M 1.91% 14
2025
Q3
– Sell
-33,779
Closed -$2.33M – 271
2025
Q2
$2.33M Buy
+33,779
New +$2.3M 0.27% 78
2025
Q1
– Sell
-80,387
Closed -$6.91M – 253
2024
Q4
$6.91M Buy
+80,387
New +$8.69M 0.99% 23

Other funds holding NVO

ABC Arbitrage's NVO Position: Q3 2026 in Review

ABC Arbitrage sold out of Novo Nordisk (NVO) in Q3 2026, closing a stake of 369,120 shares — an estimated $17.7M sold.

ABC Arbitrage first reported a position in NVO in Q4 2024 and held it in 3 quarters. The position peaked at $17.7M in Q2 2026. 383 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • ABC Arbitrage reported no remaining Novo Nordisk position as of Q3 2026 after selling out during the quarter.
  • ABC Arbitrage sold 369,120 Novo Nordisk shares in Q3 2026, an estimated $17.7M.
  • ABC Arbitrage first reported a position in Novo Nordisk in Q4 2024 and held it in 3 quarters.
  • ABC Arbitrage's Novo Nordisk position peaked at $17.7M in Q2 2026.
  • 383 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on ABC Arbitrage's 13F filing for Q3 2026, filed 23 Oct 2026.